Mona M. Abdel-Atty, Nahla A. Farag, Rabah A. T. Serya, Khaled A. M. Abouzid, & Samar Mowafy. (2021). Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: A challenging approach to combat cancer. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMona M. Abdel-Atty, Nahla A. Farag, Rabah A. T. Serya, Khaled A. M. Abouzid, and Samar Mowafy. Molecular Design, Synthesis and in Vitro Biological Evaluation of Thienopyrimidine-hydroxamic Acids as Chimeric Kinase HDAC Inhibitors: A Challenging Approach to Combat Cancer. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationMona M. Abdel-Atty, et al. Molecular Design, Synthesis and in Vitro Biological Evaluation of Thienopyrimidine-hydroxamic Acids as Chimeric Kinase HDAC Inhibitors: A Challenging Approach to Combat Cancer. Taylor & Francis Group, 2021.